Search Results 161-170 of 16367 for infliximab

  1. Ustekinumab (injection route) - Side effects & dosage - Mayo Clinic

    Cyclosporine; Dengue Tetravalent Vaccine, Live; Ebola Zaire Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus ...

  2. Postoperative Infections Clinical Trials

    ... infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite the use of these medications. Side ...

  3. Adalimumab-adbm (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Levoketoconazole; Measles Virus Vaccine, Live; Mercaptopurine; Methotrexate; Mumps Virus Vaccine, Live; Poliovirus ...

  4. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    At least one 6-week induction regimen of infliximab (≥5 mg/kg IV at Weeks 0 ... Approved biologics: infliximab, adalimumab, certolizumab, vedolizumab ...

  5. Adalimumab-atto (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-atto injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and active ankylosing ...

  6. A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    infliximab, certolizumab, adalimumab, golimumab, vedolizumab, natalizumab, within 8 weeks prior to Baseline; OR; ustekinumab within 12 weeks prior to ...

  7. Ustekinumab-srlf (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Cyclosporine; Dengue Tetravalent Vaccine, Live; Ebola Zaire Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus ...

  8. A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    At least one 6-week induction regimen of infliximab (≥ 5 mg/kg intravenous [IV] ... approved biologic agent (e.g., infliximab, adalimumab, golimumab ...

  9. Ziv-aflibercept (intravenous route) - Side effects & uses - Mayo Clinic

    Ziv-aflibercept injection is given together with other medicines (eg, fluorouracil, irinotecan, leucovorin) to treat advanced cancer of the colon or rectum. It ...

  10. How obesity affects IBD management and patient outcomes: Q&A with Amanda M. Johnson, M.D. - Mayo Clinic

    ... infliximab may perform better in patients with IBD who are obese. While there are some data to support this hypothesis, there are also contrasting data to ...